Tian Ern Food Company Limited

. 伊斯兰党 @之
毁灭国家的燎原之火

伊斯兰党一旦全面统治国家，那将不只是一次政权更替，而更像是一场对马来西亚社会结构的巨大冲击，甚至可能演变为一场浩瀚的国家灾难。
以哈迪阿旺为代表的政治伊斯兰思维，所诠释的并不是包容、多元、与现实并行的宗教价值，而是一种只允许伊斯兰式生活存在的单一路径。在这种框架下，世俗思想被视为原罪，文化差异被视为威胁，连基本的人文多样性都失去立足之地。
这种思想最危险之处，在于它把不同直接等同为错误，甚至宣称世俗价值的危害性高于杀戮与毁谤。宗教若被政治化到这种程度，不再是引导人向善的精神力量，而成为划分敌我的工具。
马来西亚长期建立起来的多元文化传统，语言、教育、生活方式、节庆信仰。在这种极端叙事中，被一步步挤出现实生活，只剩下单一、僵化的价值标准。
当国家治理被宗教教条主导，社会将不可避免地陷入紧张与对立。少数族群会感到被排斥，温和的穆斯林也可能被迫噤声，久而久之，种族矛盾的隐患被不断累积，宗教冲突的祸根被悄然催生。这不是危言耸听，而是许多国家已经付出惨痛代价的现实经验。
更令人忧虑的是，这种短路而悖逆的判断，将直接遏制国家向科学、理性与进取发展的可能。当思想被框死，学术、科技、艺术与创新都会被贴上不合教义的标签，社会将逐渐走向封闭，甚至倒退回野蛮而保守的年代。一个无法包容差异、无法接受批判的社会，注定难以与世界同行。
马来西亚的稳定与繁荣，源自多元并存、相互尊重的基础。任何试图用极端宗教观念重塑国家的政治力量，最终伤害的不只是他人，更是整个国家的未来。守护和谐，拒绝极端，才是真正对宗教、对国家负责的道路。
回教如果用于执政，最后的结果一定是出现另一个阿富汗，让时间带回1400年前惨不忍睹的奴隶制度社会，民不聊生，生不如死。

Management of NAFLD involves treating the liver disease itself as well as associated metabolic comorbidities, including diabetes, obesity, and hyperlipidemia. A recent clinical practice guideline from the American Association for the Study of Liver Diseases (AASLD) recommended that pharmacologic treatment aimed primarily at improving liver disease be limited to patients with biopsy-proven NASH and fibrosis, since patients without fibrosis generally have a favorable prognosis. As such, first-line treatment for most patients should focus on lifestyle intervention or pharmacologic treatment targeting diagnosed diabetes, obesity, or dyslipidemia. The AASLD guidelines recommend weight loss via hypocaloric diet and increased exercise, with a target of at least 7–10% weight loss to improve the majority of the histopathological features of NAFLD. The group recommends against metformin or GLP-1 agonists and recommends pioglitazone (a thiazolidinedione) in patients with biopsy-proven NASH, regardless of diabetes status, but recommends against using pioglitazone in NAFLD patients without fibrosis.

Consistent with the AASLD recommendation against metformin use in NAFLD patients, studies of metformin found no difference from placebo in steatosis, fibrosis, NAFLD activity score, or resolution of NASH. While weight and glucose control were improved with metformin, treatment with metformin did not substantially impact liver disease.

Studies of pioglitazone in NASH patients found benefits in liver function, liver fat, and NASH resolution, though significant increases in weight may be cause for concern. A recent systematic review and network meta-analysis by Sridharan et al. was consistent with our findings: pioglitazone was found to be associated with better response than standard care (odds ratio 3.8, 95% CI, 2.0 to 7.4). Evidence for other thiazolinediones was more limited and had somewhat mixed results, but findings were generally consistent with those for pioglitazone: liver fat and function and glucose measures improved, but weight also increased.

While the AASLD guidelines recommend against using GLP-1 agonists in NASH patients, we found some evidence that liraglutide improves liver fat, liver function, and HbA1c and is effective at resolving NASH and reducing weight. Exenatide performed less well but also resulted in significant reductions in liver fat and weight.

The strengths of our study include the use of systematic review processes to identify all relevant studies that meet pre-defined inclusion criteria, assessment of the internal validity (i.e., quality) of included studies, and overall evaluation of the strength of evidence using an established approach. Limitations of the present review include restriction to English-language publications and restriction to randomized trials, which may have limited generalizability to real-world populations. Larger studies with longer follow-up are needed to better quantify the long-term benefits and harms of diabetes medications to treat NAFLD, since the disease state itself, as well as many of the common metabolic conditions associated with NAFLD, are chronic conditions with long natural histories. Additionally, longer and larger studies may provide further information on clinical health outcomes and uncommon adverse effects.

Do you have fatty liver disease? - Reader's Digest Up to one in three people have something called non-alcoholic fatty liver disease (NAFLD), but many of them have no idea

#2 内幕追击：敦马和柔苏丹隔空交战，警告陛下勿让大马变 Pariah 国！ 姜还是老的辣，全马看来只剩老马敢这样了。。。虽然说国家主权很重要，但是不能因为对人民欺压惯了，在国际上还想故技重施，反咬之前所签署的承诺！

Garbling the English language Our public figures’ prowess at communicating in this lingua franca leaves much to be desired.

富贵爱心与崇德文教基金·素食便当赠有缘者 富贵爱心基金会策划，与崇德文教基金会共同推动“疫路有我相伴：爱心便当赠有缘”活动。

重五山村好，榴花忽已繁。
粽包分两髻，艾束著危冠。
旧俗方储药，羸躯亦点丹。
日斜吾事毕，一笑向杯盘。

今日端午

哈马斯 - 维基百科，自由的百科全书 伊斯兰抵抗运动（阿拉伯语：حركة المقاومة الاسلامية‎，Ḥarakat al-Muqāwamah al-ʾIslāmiyyah）[1]，简称哈马斯（حماس‎，Ḥamās），是一个成立于1987年的巴勒斯坦伊斯兰教逊尼派组织[8]，是一个集宗教性、政治性为一体....

印度疫情失控根源 暴露政治文化深层之痛 印度疫情失控，背后是政治文化深层之痛，“拼装文化”（Jugaad）的得过且过，治标不治本。官员用“数学模型”预测疫情失误，错信疫情会平息。

Suspected su***de bombing at Indonesian church wounds 14 people Two suspected su***de bombers blew themselves up outside a Catholic church in the Indonesian city of Makassar on Sunday, wounding fourteen people on the first day of the Easter Holy Week, the country's national police said.

联邦直辖区副部长山达拉拿假出国至纽西兰，如今55天长假结束后仍未露面，让网民质问他是否已经回到大马？